Thursday, October 12, 2023 7:29:04 PM
Recent NCNA News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/01/2024 10:30:15 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/01/2024 01:07:25 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/26/2024 10:04:25 AM
- NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States • GlobeNewswire Inc. • 09/25/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 10:05:26 AM
- NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 • GlobeNewswire Inc. • 09/14/2024 07:01:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2024 08:17:27 PM
- NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study • GlobeNewswire Inc. • 08/29/2024 08:01:00 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 08/15/2024 08:35:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/15/2024 08:09:05 PM
- NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/15/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/18/2024 08:02:56 PM
- NuCana to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 12:36:30 PM
- NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit • GlobeNewswire Inc. • 05/21/2024 12:00:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 08:11:50 PM
- NuCana Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/16/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2024 08:13:55 PM
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 05/01/2024 08:01:00 PM
- NuCana Announces Completion of ADS Ratio Change • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study • GlobeNewswire Inc. • 04/09/2024 08:30:00 PM
- NuCana Announces Plan to Implement ADS Ratio Change • GlobeNewswire Inc. • 03/27/2024 08:30:00 PM
- NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/20/2024 08:01:00 PM
- NuCana to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/16/2023 09:08:52 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM